dipeptidyl peptidase-4 inhibitor use with mortality among patients with type 2 diabetes and advanced chronic kidney disease
Compounded drugs are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review
This unique characteristic has helped establish Tirzepatide as one of the most recognized peptides in metabolic health and body composition research
Eur J Endocrinol 171(4):R137R152
Data and Validation: High-quality data is the lifeblood of AI
Common complaints include: Pain or aching in the feet, particularly in the arches, heels, or balls of the feet Swelling (oedema) of the feet or ankles, which may worsen throughout the day Tingling, numbness, or 'pins and needles' sensations, suggestive of peripheral neuropathy Changes in foot shape or appearance , potentially related to weight loss Increased sensitivity or discomfort when walking or standing Cramping in the feet or lower legs, particularly at night It is crucial to distinguish between symptoms that may be coincidental and those requiring urgent attention